Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
MSR1 encodes the class A macrophage scavenger receptors, which include three different types (1, 2, 3) generated by alternative splicing of MSR1. Additionally we are shipping Macrophage Scavenger Receptor 1 Kits (31) and Macrophage Scavenger Receptor 1 Proteins (19) and many more products for this protein.
Showing 10 out of 216 products:
Human Monoclonal Macrophage Scavenger Receptor 1 Primary Antibody for FACS - ABIN4897783
Tran, Ahern, Hodge, Holt, Dean, Reynolds, Hodge: Oxidative stress decreases functional airway mannose binding lectin in COPD. in PLoS ONE 2014
Show all 5 Pubmed References
Catfish (Ictalurus) Monoclonal Macrophage Scavenger Receptor 1 Primary Antibody for FACS - ABIN2479177
Brink: Quantitative vs qualitative research. in Nursing RSA = Verpleging RSA 1991
Show all 4 Pubmed References
Catfish (Ictalurus) Monoclonal Macrophage Scavenger Receptor 1 Primary Antibody for FACS - ABIN2479183
Allred, Smart, Wilson: Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors. in The Journal of biological chemistry 2006
Show all 4 Pubmed References
Catfish (Ictalurus) Monoclonal Macrophage Scavenger Receptor 1 Primary Antibody for FACS - ABIN2479179
Anatelli, Mroz, Liu, Yang, Castano, Swietlik, Hamblin: Macrophage-targeted photosensitizer conjugate delivered by intratumoral injection. in Molecular pharmaceutics 2006
Show all 4 Pubmed References
Catfish (Ictalurus) Monoclonal Macrophage Scavenger Receptor 1 Primary Antibody for IHC (fro), FACS - ABIN2479175
Aid, Langenbach, Bosetti: Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2. in Journal of neuroinflammation 2008
Show all 4 Pubmed References
Decreased expression by OxLDL in PMA-differentiated THP-1 (show GLI2 Antibodies) macrophages. Increased expression in plaque vs. nonplaque lesion areas in human carotid endarterectomy specimens (correlated with CD36 (show CD36 Antibodies) expression).
Cytokine abnormality induced by SRA (show SRA1 Antibodies)(+) cells playS an role in tissue injury, and platelet emboli or contraction band necrosis might have been the leading cause of death in our SUDI cases.
TGM2 (show TGM2 Antibodies) has a role in macrophage differentiation via mechanisms involving CD14 (show NDUFA2 Antibodies) and SR-AI receptors.
study demonstrates the elevated SR-A expression on cell surface contributes to increased susceptibility to Adenovirus serotype 5 (Ad5 (show PSEN2 Antibodies)) infection into CD14 (show NDUFA2 Antibodies)+ monocytes; SR-A-mediated Ad5 (show PSEN2 Antibodies) entry, TLR3 (show TLR3 Antibodies) signaling activation and acLDL accumulation in monocytes/ macrophages synergistically trigger the inflammatory responses and innate immunity against Ad5 (show PSEN2 Antibodies) infection
SR-A1 expression in 136 human gliomas was positively correlated with tumor grade (P<0.01), but not prognosis or tumor recurrence
The results reveal marked differences between afferent and efferent ymphatic endothelial cells and identify molecules on lymphatic vessels. Further characterizations of Siglec-1 (CD169 (show SIGLEC1 Antibodies)) and macrophage scavenger receptor 1 (MSR1/CD204), show that they are discriminatively expressed on lymphatic endothelium of the subcapsular sinus but not on lymphatic vasculature of the lymphatic sinus
SR-A1 suppresses lung cancer metastasis by downregulating SAA1 (show SAA1 Antibodies) production in tumor-associated macrophages (TAM (show CCNA1 Antibodies)).
PTX2 (show APCS Antibodies) was identified PTX2 (show APCS Antibodies) as a novel partner for FX, and both proteins cooperated to prevent their SR-AI-mediated uptake by macrophages.
we found that higher percentages of circulating CD14 (show NDUFA2 Antibodies)+CD204+, CD14 (show NDUFA2 Antibodies)+CD163 (show CD163 Antibodies)+CD204+ M2-like monocytes were significantly associated with TNM (show ODZ1 Antibodies) stage, lymph node metastasis, and histological differentiation.
Identifying N-linked glycan moiety and motifs in the cysteine-rich domain critical for N-glycosylation and intracellular trafficking of SR-AI and MARCO (show MARCO Antibodies).
Custom-produced fluorescently labeled versions of MOG or MDA-modified MOG was used to study and quantify the uptake by different macrophage populations (especially anti-inflammatory M2-type macrophages) and to identify the responsible receptor, namely SRA. The SRA-mediated uptake of MDA-modified MOG is roughly tenfold more efficient compared to that of the native form.
TMP upregulated the protein stability of ABCA1 (show ABCA1 Antibodies) without affecting ABCG1 (show ABCG1 Antibodies). Accordingly, TMP regulated the expression of SR-A, CD36 (show CD36 Antibodies), ABCA1 (show ABCA1 Antibodies) and ABCG1 (show ABCG1 Antibodies) in aortas of ApoE (show APOE Antibodies)-/- mice, which resembled the findings observed in macrophages.
LPS (show TLR4 Antibodies) may increase Ac-LDL uptake and enhance CD204 expression through MAPK/ERK (show MAPK1 Antibodies) activation in bone marrow-derived macrophages.
The low magnitude of opsonin-independent phagocytosis of Escherichia coli and unimpaired phagocytosis of Staphylococcus aureus in SR-A- or CD36 (show CD36 Antibodies)-deficient macrophages indicate that the defect in this process might not be responsible for the reported impaired bacteria clearance in mice deficient in these receptors.
Data (including data from studies conducted in cells from knockout mice) suggest that signaling via Lpar1 (show LPAR1 Antibodies), Cd14 (show CD14 Antibodies), and Scara1 mediates uptake of oxidized LDL by macrophages leading to foam cell formation; lysophosphatidic acid (LPA (show LPA Antibodies)) induces expression of Cd14 (show CD14 Antibodies) and Scara1 in macrophages. (Lpar1 (show LPAR1 Antibodies) = LPA receptor 1 (show LPAR1 Antibodies); Cd14 (show CD14 Antibodies) = monocyte differentiation antigen CD14 (show CD14 Antibodies); Scara1 = scavenger receptor class A type I)
Common damage-associated molecular patterns (DAMPs) were internalized through the class A scavenger receptors MSR1 and MARCO (show MARCO Antibodies) in vitro. In ischemic murine brain, DAMP (show AMPH Antibodies) internalization was largely mediated by MSR1. Combined deficiency for Msr1 and Marco (show MARCO Antibodies) in infiltrating myeloid cells caused impaired clearance of DAMPs, more severe inflammation, and exacerbated neuronal injury in a murine model of ischemic stroke.
PTX2 (show PITX2 Antibodies) was identified PTX2 (show PITX2 Antibodies) as a novel partner for FX, and both proteins cooperated to prevent their SR-AI-mediated uptake by macrophages.
this study shows that Msr1 functions as co-receptor along with TLRs for HMGB1 (show HMGB1 Antibodies) in M1-type inflammatory macrophages
Our findings demonstrated that ClC-3 (show CLCN3 Antibodies) deficiency inhibits atherosclerotic lesion development, possibly via suppression of JNK (show MAPK8 Antibodies)/p38 MAPK (show MAPK14 Antibodies) dependent SR-A expression and foam cell formation
FAP (show FAP Antibodies)-cleaved collagen is a substrate for SR-A-dependent macrophage adhesion.
This gene encodes the class A macrophage scavenger receptors, which include three different types (1, 2, 3) generated by alternative splicing of this gene. These receptors or isoforms are macrophage-specific trimeric integral membrane glycoproteins and have been implicated in many macrophage-associated physiological and pathological processes including atherosclerosis, Alzheimer's disease, and host defense. The isoforms type 1 and type 2 are functional receptors and are able to mediate the endocytosis of modified low density lipoproteins (LDLs). The isoform type 3 does not internalize modified LDL (acetyl-LDL) despite having the domain shown to mediate this function in the types 1 and 2 isoforms. It has an altered intracellular processing and is trapped within the endoplasmic reticulum, making it unable to perform endocytosis. The isoform type 3 can inhibit the function of isoforms type 1 and type 2 when co-expressed, indicating a dominant negative effect and suggesting a mechanism for regulation of scavenger receptor activity in macrophages.
macrophage acetylated LDL receptor I and II
, macrophage scavenger receptor type III
, macrophage scavenger receptor types I and II
, scavenger receptor class A member 1
, scavenger receptor class A, member 1
, scavenger receptor type A
, macrophage scavenger receptor 1
, macrophage scavenger receptor type I
, macrophage scavenger receptor types I and II-like